Anna Murzhenko

Q: What is Anna Murzhenko email address?

Email Anna Murzhenko at amu@ymabs.com. This email is the most updated Anna Murzhenko email found in 2026.

Q: How to contact Anna Murzhenko?

To contact Anna Murzhenko send an email to amu@ymabs.com. (updated on October 30, 2024)

Head of Medical Affairs at Y-mAbs Therapeutics, Inc. | New York City Metropolitan Area

About Anna Murzhenko

As the Vice President and Head of Medical Affairs at Y-mAbs Therapeutics, Inc., Anna Murzhenko has established herself as a pivotal leader in the pharmaceutical industry, particularly in the realm of oncology and immunotherapy. With a reputation for building high-performing Medical Affairs teams from the ground up, Anna leverages her extensive leadership and management experience to foster a culture of excellence and innovation. Under her guidance, Y-mAbs successfully launched its first FDA-approved product, a significant milestone that underscores her expertise in navigating the complexities of product launch and regulatory negotiations.

Anna's role encompasses leading the US Medical Affairs strategy while also spearheading global collaborations that enhance the company's footprint in the market. Her ability to develop meaningful partnerships with key medical experts and external stakeholders has been instrumental in driving the company's mission forward. She is adept at translating complex clinical data into actionable insights, ensuring that the Medical Affairs team effectively communicates the value of Y-mAbs' products to healthcare professionals and patients alike.

Her strong track record in hiring and retaining top talent is complemented by her commitment to personnel coaching and development, which emphasizes achieving greatness through empowering teams and individuals. With a robust background in clinical trials, regulatory affairs, and market access, Anna is well-versed in the nuances of the pharmaceutical landscape, particularly in neurology and nephrology. Her strategic vision and operational acumen continue to position Y-mAbs Therapeutics as a leader in the industry, driving advancements in patient care and therapeutic innovation.

Anna Murzhenko Work